- Datum05.01.2026
- Uhrzeit19:00 - 20:30 Uhr
- Preis49,99 €
Hikma Pharmaceuticals PLC Aktie
Verkaufen
Kaufen
Hikma Pharmaceuticals PLC Chart
Charts analysieren
wie die Profis?
Nutze unser Profi-Charting-Tool für Deine eigenen Analysen
Chart analysieren
Hikma Pharmaceuticals PLC Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (L&S)
-1,69 %
Intraday
-2,23 %
1 Woche
-14,22 %
1 Monat
-26,47 %
Seit Jahresbeginn
-22,57 %
1 Jahr
6,06 %
3 Jahre
-40,60 %
5 Jahre
-42,48 %
10 Jahre
Passender Service zu Hikma Pharmaceuticals PLC
Webinar zu Hikma Pharmaceuticals PLC
Kursinformationen (L&S)
- Tagestief / Hoch (€)-
- 52W-Tief / Hoch (€)17,200-28,400
- Jahrestief / Hoch (€)---
- Schlusskurs (Vortag)
- Eröffnungskurs
Wichtigste Eigenschaften
Dividenden von Hikma Pharmaceuticals PLC
| Ex-Datum | Fiskaljahr | Dividende | Rendite |
|---|---|---|---|
| - | 2027 (e) | ||
| - | 2026 (e) | ||
| - | 2025 (e) | ||
| 14.08.2025 | 2025 | 0,36 $ | 1,44 % |
| 20.03.2025 | 2024 | 0,48 $ | 1,77 % |
| 15.08.2024 | 2024 | 0,32 $ | 1,21 % |
| 21.03.2024 | 2024 | 0,47 $ | 1,89 % |
| 10.08.2023 | 2023 | 0,25 $ | 0,90 % |
| 23.03.2023 | 2022 | 0,37 $ | 1,78 % |
| 18.08.2022 | 2022 | 0,19 $ | 1,05 % |
| 17.03.2022 | 2021 | 0,36 $ | 1,33 % |
| 19.08.2021 | 2021 | 0,18 $ | 0,51 % |
| 18.03.2021 | 2020 | 0,34 $ | 1,11 % |
| 20.08.2020 | 2020 | 0,16 $ | 0,52 % |
| 19.03.2020 | 2019 | 0,30 $ | 1,47 % |
| 22.08.2019 | 2019 | 0,14 $ | 0,57 % |
| 04.04.2019 | 2018 | 0,26 $ | 1,10 % |
| 23.08.2018 | 2018 | 0,12 $ | 0,49 % |
| 05.04.2018 | 2017 | 0,23 $ | 1,34 % |
| 24.08.2017 | 2017 | 0,11 $ | 0,71 % |
| 01.09.2016 | 2016 | 0,11 $ | 0,40 % |
| 06.04.2017 | 2016 | 0,22 $ | 0,92 % |
| 07.04.2016 | 2015 | 0,21 $ | 0,73 % |
| 27.08.2015 | 2015 | 0,11 $ | - |
| 16.04.2015 | 2014 | 0,21 $ | - |
| 27.08.2014 | 2014 | 0,11 $ | - |
| 23.04.2014 | 2013 | 0,17 $ | - |
| 04.09.2013 | 2013 | 0,10 $ | - |
| 17.04.2013 | 2012 | 0,10 $ | - |
| 29.08.2012 | 2012 | 0,06 $ | - |
| 07.09.2011 | 2011 | 0,055 $ | - |
| 18.04.2012 | 2011 | 0,075 $ | - |
| 13.04.2011 | 2010 | 0,075 $ | - |
| 08.09.2010 | 2010 | 0,055 $ | - |
| 14.04.2010 | 2009 | 0,065 $ | - |
| 16.09.2009 | 2009 | 0,045 $ | - |
| 29.04.2009 | 2008 | 0,04 $ | - |
| 17.09.2008 | 2008 | 0,035 $ | - |
| 30.04.2008 | 2007 | 0,04 $ | - |
| 26.09.2007 | 2007 | 0,035 $ | - |
| 16.05.2007 | 2006 | 0,04 $ | - |
| 27.09.2006 | 2006 | 0,03 $ | - |
| 26.04.2006 | 2005 | 0,0089 $ | - |
Termine von Hikma Pharmaceuticals PLC
- Feb26Hikma Pharmaceuticals PLCQ4 2025 Earnings Release
- Aug6Hikma Pharmaceuticals PLCQ2 2026 Earnings Release
- Feb25Hikma Pharmaceuticals PLCQ4 2026 Earnings Release
Beschreibung
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.
